Process for analyzing tear fluid

• US 7,429,465 B2
• Filed: 09/03/2003
• Issued: 09/30/2008
• Est. Priority Date: 09/13/2002
• Status: Active Grant

• Current Assignee: Alcon Incorporated
• Original Assignee: Novartis Ag
• Inventors: Müller, Achim, Schmieder, Roland, Schmid, Katharina
• Primary Examiner(s): Saucier; Sandra E
• Assistant Examiner(s): Hanley; Susan
• Application Number:
  US10/653,866
• Publication Number:
  US 20050176158A1
• Time in Patent Office: 1,854 Days
• Field of Search: 435/4, 435/40.5, 604/294, 604/372, 604/297, 604/573, 600/573
• US Class Current: 435/40.5
• CPC Class Codes: A61B 2010/0067 Tear or lachrymal fluid
• CPC Class Codes: G01N 33/487 of liquid biological material

Abstract

The present invention concerns a process for analyzing an analyte in a hydrogel contact lens following its wear on the eye, comprising the steps of

• (a) physically or chemically inducing a volume reduction of the hydrogel contact lens and thereby squeezing the analyte out of the polymer material making up the contact lens and
• (b) feeding the analyte obtained according to step (a) into an analyzer.

The process of the invention provides a new concept for noninvasively measuring various analytes occurring in the tear fluid that is comfortable to the user.

Claims

1. A process for analyzing at least one analyte contained in tear fluid which is present in a hydrogel contact lens which has been worn on the eye, wherein the hydrogel is a polymer, comprising the steps of:

(a) chemically inducing a reduction in the volume of the hydrogel lens by crosslinking the polymer, thereby squeezing tear fluid that contains the at least one analyte from the polymer; and

(b) contacting the tear fluid that contains the at least one analyte according to step (a) with an analytical instrument to detect the analyte.

2. The process of to claim 1, wherein the analyte is glucose or a hormone.

3. The process of claim 1, wherein more than one analyte is analyzed concurrently.

4. The process of claim 1, wherein the hydrogel contact lens comprises a HEMA homo- or copolymer, a homo or copolymer derived from a crosslinkable polyalkylene oxide or a modified polyvinyl alcohol.

5. The process of claim 1, wherein the hydrogel contact lens comprises a polyvinyl alcohol which is obtained by crosslinking a polyvinyl alcohol prepolymer having a molecular weight of at least about 2000 and comprising, based on the number of hydroxy groups, from approximately 0.5 to approximately 80 % of units of formula

6. The process of claim 5, wherein R is methylene, R₁ is hydrogen, and R₂ is a group —

CO—

R₃, wherein R₃ is ethenyl or 2-propenyl.

7. The process of claim 5, wherein the polyvinyl alcohol prepolymer additionally comprises units of formula (5)

8. The process of claim 5, wherein the polyvinyl alcohol prepolymer additionally comprises units of formula (6)

9. The process of claim 1, wherein the crosslinking step is accomplished by reacting the polymer with an unsaturated compound that is capable of reacting with the polymer to produce a modified hydrogel polymer having unsaturated groups and photocrosslinking the modified polymer to produce a crosslinked hydrogel polymer.

10. The process of claim 7, inducing the volume reduction of the contact lens by reacting the polymer comprising at least one unit of formula (5) with an unsaturated compound that is capable of reacting with the polymer to produce a modified polymer having unsaturated groups that are capable of undergoing a polymerization reaction and photocrosslinking the modified polymer to produce a crosslinked polymer.

11. The process of claim 8, inducing the volume reduction of the contact lens by subjecting the polymer comprising at least one unit of formula (6) to a polymerization reaction with a triplet initiator.

12. The process of claim 1, further comprising the step of reacting the polymer with an unsaturated compound that is capable of reacting with the hydrogel polymer to produce a modified polymer having unsaturated groups that are capable of undergoing a polymerization reaction.